Association of Biotechnology Led Enterprises

News

Seeking solutions for challenges shared by Industries

TechEx.in is scouting solutions for the problem statements shared by our Industry clients as part of the TechNet service offered by us

Aug 31, 2022

By : Team ABLE

Bharat Biotech completes clinical development for phase III trials and booster doses for BBV154 intranasal covid vaccine.

BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.

Aug 30, 2022

By : Team ABLE

Eyestem raises $6.4 Million

ABLE Member Eyestem raises $6.4 million in Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya. The investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic

Aug 30, 2022

By : Team ABLE

Serum Institute CEO Meets President and Prime Minister

ABLE Member, Serum Institute of India’s CEO Adar Poonawalla called on Prime Minister Narendra Modi on August 24 and congratulated him for his leadership in the fight against the COVID-19 pandemic.

Aug 30, 2022

By : Team ABLE

Karnataka IT-BT Minister breaks ground for new block @ Center for Human Genetics

The Center for Human Genetics( CHG) , one of the country’s premier research centers on rare genetic diseases, will get a new 45,000 sq. ft building that will increase the genetic testing services significantly in a few years.

Aug 30, 2022

By : Narayanan Suresh